Dominick Colangelo Vericel Corp (VCEL) insider trading activity

Dominick Colangelo is President and CEO of Vericel Corp. Currently has a direct ownership of 220,937 shares of VCEL, which is worth approximately $12.8 Million. The most recent transaction as insider was on Nov 14, 2024, when has been sold 17,500 shares (Common Stock) at a price of $53.93 per share, resulting in proceeds of $943,775. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 221K

0% 3M change

29.97% 12M change

Total Value Held $12.8 Million

Dominick Colangelo Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 14 2024	SELL Open market or private sale	$943,775 $53.93 p/Share	17,500 Reduced 7.34%	220,937 Common Stock
Nov 14 2024	BUY Exercise of conversion of derivative security	$52,850 $3.02 p/Share	17,500 Added 6.84%	238,437 Common Stock
Nov 13 2024	SELL Open market or private sale	$972,475 $55.57 p/Share	17,500 Reduced 7.34%	220,937 Common Stock
Nov 13 2024	BUY Exercise of conversion of derivative security	$52,850 $3.02 p/Share	17,500 Added 6.84%	238,437 Common Stock
Oct 17 2024	SELL Open market or private sale	$705,950 $40.34 p/Share	17,500 Reduced 7.34%	220,937 Common Stock
Oct 17 2024	BUY Exercise of conversion of derivative security	$52,850 $3.02 p/Share	17,500 Added 6.84%	238,437 Common Stock
Oct 16 2024	SELL Open market or private sale	$724,150 $41.38 p/Share	17,500 Reduced 7.34%	220,937 Common Stock
Oct 16 2024	BUY Exercise of conversion of derivative security	$52,850 $3.02 p/Share	17,500 Added 6.84%	238,437 Common Stock
Sep 12 2024	SELL Open market or private sale	$768,250 $43.9 p/Share	17,500 Reduced 7.34%	220,937 Common Stock
Sep 12 2024	BUY Exercise of conversion of derivative security	$52,850 $3.02 p/Share	17,500 Added 6.84%	238,437 Common Stock
Sep 11 2024	SELL Open market or private sale	$758,975 $43.37 p/Share	17,500 Reduced 7.34%	220,937 Common Stock
Sep 11 2024	BUY Exercise of conversion of derivative security	$52,850 $3.02 p/Share	17,500 Added 6.84%	238,437 Common Stock
Aug 15 2024	SELL Open market or private sale	$809,200 $46.24 p/Share	17,500 Reduced 7.34%	220,937 Common Stock
Aug 15 2024	BUY Exercise of conversion of derivative security	$52,850 $3.02 p/Share	17,500 Added 6.84%	238,437 Common Stock
Aug 14 2024	SELL Open market or private sale	$790,475 $45.17 p/Share	17,500 Reduced 7.34%	220,937 Common Stock
Aug 14 2024	BUY Exercise of conversion of derivative security	$52,850 $3.02 p/Share	17,500 Added 6.84%	238,437 Common Stock
Jul 18 2024	SELL Open market or private sale	$899,500 $51.4 p/Share	17,500 Reduced 7.34%	220,937 Common Stock
Jul 18 2024	BUY Exercise of conversion of derivative security	$52,850 $3.02 p/Share	17,500 Added 6.84%	238,437 Common Stock
Jul 17 2024	SELL Open market or private sale	$902,125 $51.55 p/Share	17,500 Reduced 7.34%	220,937 Common Stock
Jul 17 2024	BUY Exercise of conversion of derivative security	$52,850 $3.02 p/Share	17,500 Added 6.84%	238,437 Common Stock
Jun 13 2024	SELL Open market or private sale	$754,250 $43.1 p/Share	17,500 Reduced 7.35%	220,752 Common Stock
Jun 13 2024	BUY Exercise of conversion of derivative security	$52,850 $3.02 p/Share	17,500 Added 6.84%	238,252 Common Stock
Jun 12 2024	SELL Open market or private sale	$772,100 $44.12 p/Share	17,500 Reduced 7.35%	220,752 Common Stock
Jun 12 2024	BUY Exercise of conversion of derivative security	$52,850 $3.02 p/Share	17,500 Added 6.84%	238,252 Common Stock
May 16 2024	SELL Open market or private sale	$837,375 $47.85 p/Share	17,500 Reduced 7.35%	220,752 Common Stock

Also insider at

TRVI

Trevi Therapeutics, Inc. Healthcare